{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T14:35:27Z","timestamp":1782398127883,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T00:00:00Z","timestamp":1523318400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81373190"],"award-info":[{"award-number":["81373190"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571587"],"award-info":[{"award-number":["81571587"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science Foundation of Beijing","award":["7172178"],"award-info":[{"award-number":["7172178"]}]},{"name":"CAMS Initiative for Innovative Medicine","award":["2017-12M-3-001"],"award-info":[{"award-number":["2017-12M-3-001"]}]},{"name":"The National Key Research and Development Program of China","award":["2016YFC0901500"],"award-info":[{"award-number":["2016YFC0901500"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13075-018-1567-2","type":"journal-article","created":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T11:20:22Z","timestamp":1524136822000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Failure of remission induction by glucocorticoids alone or in combination with immunosuppressive agents in IgG4-related disease: a prospective study of 215 patients"],"prefix":"10.1186","volume":"20","author":[{"given":"Liwen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panpan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruie","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyun","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengchun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7808-9867","authenticated-orcid":false,"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,10]]},"reference":[{"issue":"6","key":"1567_CR1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1056\/NEJMra1104650","volume":"366","author":"JH Stone","year":"2012","unstructured":"Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366(6):539\u201351.","journal-title":"N Engl J Med."},{"issue":"9976","key":"1567_CR2","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/S0140-6736(14)60720-0","volume":"385","author":"T Kamisawa","year":"2015","unstructured":"Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. Lancet (London, England). 2015;385(9976):1460\u201371.","journal-title":"Lancet (London, England)"},{"issue":"7","key":"1567_CR3","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.mayocp.2015.03.020","volume":"90","author":"JH Stone","year":"2015","unstructured":"Stone JH, Brito-Zeron P, Bosch X, Ramos-Casals M. Diagnostic approach to the complexity of IgG4-related disease. Mayo Clin Proc. 2015;90(7):927\u201339.","journal-title":"Mayo Clin Proc."},{"issue":"2","key":"1567_CR4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.berh.2016.07.003","volume":"30","author":"P Brito-Zeron","year":"2016","unstructured":"Brito-Zeron P, Bosch X, Ramos-Casals M, Stone JH. IgG4-related disease: advances in the diagnosis and treatment. Best Pract Res Clin Rheumatol. 2016;30(2):261\u201378.","journal-title":"Best Pract Res Clin Rheumatol."},{"issue":"7","key":"1567_CR5","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1002\/art.39132","volume":"67","author":"A Khosroshahi","year":"2015","unstructured":"Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN, et al. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol. 2015;67(7):1688\u201399.","journal-title":"Arthritis Rheumatol."},{"issue":"12","key":"1567_CR6","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1136\/gutjnl-2012-303617","volume":"62","author":"PA Hart","year":"2013","unstructured":"Hart PA, Kamisawa T, Brugge WR, Chung JB, Culver EL, Czako L, et al. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut. 2013;62(12):1771\u20136.","journal-title":"Gut."},{"issue":"11","key":"1567_CR7","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1136\/gut.2008.172908","volume":"58","author":"T Kamisawa","year":"2009","unstructured":"Kamisawa T, Shimosegawa T, Okazaki K, Nishino T, Watanabe H, Kanno A, et al. Standard steroid treatment for autoimmune pancreatitis. Gut. 2009;58(11):1504\u20137.","journal-title":"Gut."},{"issue":"10","key":"1567_CR8","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.cgh.2009.03.021","volume":"7","author":"NS Sandanayake","year":"2009","unstructured":"Sandanayake NS, Church NI, Chapman MH, Johnson GJ, Dhar DK, Amin Z, et al. Presentation and management of post-treatment relapse in autoimmune pancreatitis\/immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol. 2009;7(10):1089\u201396.","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"11","key":"1567_CR9","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1093\/rheumatology\/kev203","volume":"54","author":"W Lin","year":"2015","unstructured":"Lin W, Lu S, Chen H, Wu Q, Fei Y, Li M, et al. Clinical characteristics of immunoglobulin G4-related disease: a prospective study of 118 Chinese patients. Rheumatology (Oxford). 2015;54(11):1982\u201390.","journal-title":"Rheumatology (Oxford)."},{"issue":"2","key":"1567_CR10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3109\/03009742.2015.1055796","volume":"45","author":"C Campochiaro","year":"2016","unstructured":"Campochiaro C, Ramirez GA, Bozzolo EP, Lanzillotta M, Berti A, Baldissera E, et al. IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients. Scand J Rheumatol. 2016;45(2):135\u201345.","journal-title":"Scand J Rheumatol."},{"issue":"1","key":"1567_CR11","doi-asserted-by":"publisher","first-page":"6195","DOI":"10.1038\/s41598-017-06520-5","volume":"7","author":"F Yunyun","year":"2017","unstructured":"Yunyun F, Yu C, Panpan Z, Hua C, Di W, Lidan Z, et al. Efficacy of Cyclophosphamide treatment for immunoglobulin G4-related disease with addition of glucocorticoids. Sci Rep. 2017;7(1):6195.","journal-title":"Sci Rep"},{"issue":"11","key":"1567_CR12","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1136\/gutjnl-2012-302886","volume":"62","author":"PA Hart","year":"2013","unstructured":"Hart PA, Topazian MD, Witzig TE, Clain JE, Gleeson FC, Klebig RR, et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut. 2013;62(11):1607\u201315.","journal-title":"Gut."},{"issue":"4","key":"1567_CR13","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/j.1445-5994.2012.02964.x","volume":"43","author":"JJ Bosco","year":"2013","unstructured":"Bosco JJ, Suan D, Varikatt W, Lin MW. Extra-pancreatic manifestations of IgG4-related systemic disease: a single-centre experience of treatment with combined immunosuppression. Intern Med J. 2013;43(4):417\u201323.","journal-title":"Intern Med J."},{"issue":"10","key":"1567_CR14","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1093\/rheumatology\/kev244","volume":"54","author":"E Della-Torre","year":"2015","unstructured":"Della-Torre E, Campochiaro C, Bozzolo EP, Dagna L, Scotti R, Nicoletti R, et al. Methotrexate for maintenance of remission in IgG4-related disease. Rheumatology (Oxford). 2015;54(10):1934\u20136.","journal-title":"Rheumatology (Oxford)."},{"issue":"6","key":"1567_CR15","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/imj.13430","volume":"47","author":"Y Wang","year":"2017","unstructured":"Wang Y, Li K, Gao D, Luo G, Zhao Y, Wang X, et al. Combination therapy of leflunomide and glucocorticoids for the maintenance of remission in patients with IgG4-related disease: a retrospective study and literature review. Intern Med J. 2017;47(6):680\u20139.","journal-title":"Intern Med J."},{"issue":"2","key":"1567_CR16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00296-017-3730-5","volume":"38","author":"N Gupta","year":"2018","unstructured":"Gupta N, Mathew J, Mohan H, Chowdhury SD, Kurien RT, Christopher DJ, et al. Addition of second-line steroid sparing immunosuppressants like mycophenolate mofetil improves outcome of immunoglobulin G4-related disease (IgG4-RD): a series from a tertiary care teaching hospital in South India. Rheumatol Int. 2018;38(2):203\u20139.","journal-title":"Rheumatol Int."},{"issue":"32","key":"1567_CR17","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001366","volume":"94","author":"BA McMahon","year":"2015","unstructured":"McMahon BA, Novick T, Scheel PJ, Bagnasco S, Atta MG. Rituximab for the treatment of IgG4-related tubulointerstitial nephritis: case report and review of the literature. Medicine (Baltimore). 2015;94(32):e1366.","journal-title":"Medicine (Baltimore)."},{"issue":"6","key":"1567_CR18","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1093\/rheumatology\/kev438","volume":"55","author":"ZS Wallace","year":"2016","unstructured":"Wallace ZS, Mattoo H, Mahajan VS, Kulikova M, Lu L, Deshpande V, et al. Predictors of disease relapse in IgG4-related disease following rituximab. Rheumatology (Oxford, England). 2016;55(6):1000\u20138.","journal-title":"Rheumatology (Oxford, England)"},{"issue":"12","key":"1567_CR19","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006400","volume":"96","author":"W Liu","year":"2017","unstructured":"Liu W, Chen W, He X, Qu Q, Hong T, Li B. Poor response of initial steroid therapy for IgG4-related sclerosing cholangitis with multiple organs affected. Medicine (Baltimore). 2017;96(12):e6400.","journal-title":"Medicine (Baltimore)."},{"issue":"3","key":"1567_CR20","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1164\/rccm.201309-1632LE","volume":"189","author":"X Sun","year":"2014","unstructured":"Sun X, Peng M, Hou X, Feng R, Xu Z. Refractory IgG4-related lung disease with constitutional symptoms and severe inflammation. Am J Respir Crit Care Med. 2014;189(3):374\u20135.","journal-title":"Am J Respir Crit Care Med."},{"issue":"1","key":"1567_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","volume":"22","author":"H Umehara","year":"2012","unstructured":"Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22(1):21\u201330.","journal-title":"Mod Rheumatol."},{"issue":"1","key":"1567_CR22","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3109\/03009742.2013.822094","volume":"43","author":"H Chen","year":"2014","unstructured":"Chen H, Lin W, Wang Q, Wu Q, Wang L, Fei Y, et al. IgG4-related disease in a Chinese cohort: a prospective study. Scand J Rheumatol. 2014;43(1):70\u20134.","journal-title":"Scand J Rheumatol."},{"key":"1567_CR23","doi-asserted-by":"publisher","first-page":"259408","DOI":"10.1155\/2012\/259408","volume":"2012","author":"MN Carruthers","year":"2012","unstructured":"Carruthers MN, Stone JH, Deshpande V, Khosroshahi A. Development of an IgG4-RD responder index. Int J Rheumatol. 2012;2012:259408.","journal-title":"Int J Rheumatol."},{"issue":"9","key":"1567_CR24","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/nrrheum.2014.118","volume":"10","author":"K Franklyn","year":"2014","unstructured":"Franklyn K, Hoi A, Nikpour M, Morand EF. The need to define treatment goals for systemic lupus erythematosus. Nat Rev Rheumatol. 2014;10(9):567\u201371.","journal-title":"Nat Rev Rheumatol."},{"issue":"1","key":"1567_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2015-207524","volume":"75","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Breedveld FC, Burmester GR, Bykerk V, Dougados M, Emery P, et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis. 2016;75(1):3\u201315.","journal-title":"Ann Rheum Dis."},{"issue":"9689","key":"1567_CR26","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S0140-6736(09)61340-4","volume":"374","author":"P Verdecchia","year":"2009","unstructured":"Verdecchia P, Staessen JA, Angeli F, de Simone G, Achilli A, Ganau A, et al. Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial. Lancet (London, England). 2009;374(9689):525\u201333.","journal-title":"Lancet (London, England)"},{"issue":"11","key":"1567_CR27","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1136\/ard.2007.071092","volume":"66","author":"SM Verstappen","year":"2007","unstructured":"Verstappen SM, Jacobs JW, van der Veen MJ, Heurkens AH, Schenk Y, ter Borg EJ, et al. Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial). Ann Rheum Dis. 2007;66(11):1443\u20139.","journal-title":"Ann Rheum Dis."},{"issue":"9430","key":"1567_CR28","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0140-6736(04)16676-2","volume":"364","author":"C Grigor","year":"2004","unstructured":"Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet (London, England). 2004;364(9430):263\u20139.","journal-title":"Lancet (London, England)"},{"issue":"4","key":"1567_CR29","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/rheumatology\/kes358","volume":"52","author":"Y Shimizu","year":"2013","unstructured":"Shimizu Y, Yamamoto M, Naishiro Y, Sudoh G, Ishigami K, Yajima H, et al. Necessity of early intervention for IgG4-related disease\u2013delayed treatment induces fibrosis progression. Rheumatology (Oxford). 2013;52(4):679\u201383.","journal-title":"Rheumatology (Oxford)."},{"issue":"26","key":"1567_CR30","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004002","volume":"95","author":"P Brito-Zeron","year":"2016","unstructured":"Brito-Zeron P, Kostov B, Bosch X, Acar-Denizli N, Ramos-Casals M, Stone JH. Therapeutic approach to IgG4-related disease: a systematic review. Medicine (Baltimore). 2016;95(26):e4002.","journal-title":"Medicine (Baltimore)."},{"issue":"2","key":"1567_CR31","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/all.12320","volume":"69","author":"E Della Torre","year":"2014","unstructured":"Della Torre E, Mattoo H, Mahajan VS, Carruthers M, Pillai S, Stone JH. Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease. Allergy. 2014;69(2):269\u201372.","journal-title":"Allergy."},{"issue":"13","key":"1567_CR32","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.4103\/0366-6999.184459","volume":"129","author":"Y Chen","year":"2016","unstructured":"Chen Y, Zhao JZ, Feng RE, Shi JH, Li XM, Fei YY, et al. Types of organ involvement in patients with immunoglobulin G4-related disease. Chin Med J. 2016;129(13):1525\u201332.","journal-title":"Chin Med J."},{"issue":"1","key":"1567_CR33","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1136\/annrheumdis-2014-205233","volume":"74","author":"ZS Wallace","year":"2015","unstructured":"Wallace ZS, Mattoo H, Carruthers M, Mahajan VS, Della Torre E, Lee H, et al. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis. 2015;74(1):190\u20135.","journal-title":"Ann Rheum Dis."},{"issue":"5","key":"1567_CR34","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/1756-185X.13088","volume":"20","author":"Q Wu","year":"2017","unstructured":"Wu Q, Chang J, Chen H, Chen Y, Yang H, Fei Y, et al. Efficacy between high and medium doses of glucocorticoid therapy in remission induction of IgG4-related diseases: a preliminary randomized controlled trial. Int J Rheum Dis. 2017;20(5):639\u201346.","journal-title":"Int J Rheum Dis."}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1567-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-018-1567-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1567-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T19:10:26Z","timestamp":1554837026000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-018-1567-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,10]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1567"],"URL":"https:\/\/doi.org\/10.1186\/s13075-018-1567-2","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,10]]},"assertion":[{"value":"11 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Ethics Committee of Peking Union Medical College Hospital. All enrolled patients consented to attend this cohort study and gave written, signed informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We obtained consent for publication from all the individuals on whom detailed information was included in the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"65"}}